Preparing for Another Level of Innovation

Dr Mark FishmanHow does Novartis use stem cell patents? How does it view peers like Pfizer engaging in this field? Interview with Dr Mark Fishman, President of the Novartis Institutes for BioMedical Research and Member of the Executive Committee of Novartis, February 2009.

 

 

 

 

 

 

 

 



If you would like to read more, please proceed to the download section.

Important: After pressing "Buy this article (PayPal)" below you will be taken to the PaypPal checkout page. There you must press the orange "Return To BioBusinessMedia" button in order to download your article.
In buying this article you agree with our Terms & Conditions which you can consult here.

Interview 1 page - advert free

Go back

EXCLUSIVE STEM CELLS COLLECTION

Top 10 Tags

All Tags (2094)